CCND1 gene amplification and cyclin D1 protein overexpression are indicator
s for poor prognosis in invasive head and neck carcinomas. Increased CCND1
gene dosage is a more sensitive prognostic factor than protein overexpressi
on as evaluated by conventional immunohistochemical techniques. Qualitative
immunohistochemistry cannot distinguish cyclin D1 overexpression accompani
ed by amplification of the CCND1 gene from overexpression associated with n
ormal CCND1 gene copy number. To improve the sensitivity of cyclin D1 prote
in determination, We applied quantitative techniques of image analysis to e
valuate cyclin D1 in 54 head and neck carcinomas. There was a significantly
higher rate of occurrence of adverse events (P = 0.043) among patients wit
h CCND1 gene amplification than among those without gene amplification, The
re was a strong association between CCND1 gene amplification (as detected b
y Southern blot analysis) and the highest nuclear score (by image cytometry
of the immunostained tumor sections). The predominance of cells in the low
est nuclear score category was significantly associated with normal copy nu
mber (P = 0.005), Conversely, the highest nuclear score was a significant p
redictor of gene dosage (P = 0.02), Similarly, high nuclear score was a goo
d predictor of death as the final outcome of the disease (P = 0.01), Althou
gh somewhat less accurate than Southern blotting, image cytometry of immuno
histochemical cyclin D1 stain appears to be a promising tool that could be
useful for other tumor marker expression studies.